AVS Bio Revenue and Competitors
Estimated Revenue & Valuation
- AVS Bio's estimated annual revenue is currently $17.7M per year.
- AVS Bio's estimated revenue per employee is $201,000
Employee Data
- AVS Bio has 88 Employees.
- AVS Bio grew their employee count by 44% last year.
AVS Bio's People
Name | Title | Email/Phone |
---|
AVS Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $22.9M | 114 | 24% | N/A | N/A |
#2 | $1105.9M | 5502 | 3% | N/A | N/A |
#3 | $47M | 234 | 26% | N/A | N/A |
#4 | $9.2M | 46 | 5% | N/A | N/A |
#5 | $10192.5M | 50709 | 3% | N/A | N/A |
#6 | $6M | 30 | 0% | N/A | N/A |
#7 | $110.1M | 548 | 9% | N/A | N/A |
#8 | $8.8M | 44 | -2% | N/A | N/A |
#9 | $21.3M | 106 | -27% | N/A | N/A |
#10 | $27.7M | 138 | -28% | N/A | N/A |
What Is AVS Bio?
AVS Bio is a global leader in providing Specific Pathogen Free (SPF) eggs, laboratory products, and testing services to the biologics industry. Our world-class products and services are trusted by customers in both human and animal health markets.\n\nOur commitment to quality, biosecurity, and scientific innovation has set the standard for our industry for over five decades. We are dedicated to relentlessly improving and expanding our offerings to meet the evolving needs of our dynamic customer base.\n\nAt AVS Bio, we value our employees and are actively hiring for positions in New York, Connecticut, Illinois, and Missouri. We post new job opportunities regularly here. If you are passionate about contributing to a team that is significantly impacting the biologics industry, we encourage you to apply.
keywords:N/AN/A
Total Funding
88
Number of Employees
$17.7M
Revenue (est)
44%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $31.1M | 88 | 1% | N/A |
#2 | $12.8M | 88 | 21% | N/A |
#3 | $24.8M | 92 | -7% | N/A |
#4 | $7.5M | 92 | 24% | N/A |
#5 | $15M | 92 | 7% | N/A |